US equities
|
NVDA
$236.92
▲+1.27%
SPCX
$165.36
▲+4.03%
MU
$1,063.26
▼-1.08%
TSLA
$378.28
▲+2.08%
MSFT
$526.21
▲+1.68%
INTC
$116.28
▼-2.55%
SNDK
$1,720.85
▲+0.05%
AMD
$628.00
▼-0.93%
NVDA
$236.92
▲+1.27%
SPCX
$165.36
▲+4.03%
MU
$1,063.26
▼-1.08%
TSLA
$378.28
▲+2.08%
MSFT
$526.21
▲+1.68%
INTC
$116.28
▼-2.55%
SNDK
$1,720.85
▲+0.05%
AMD
$628.00
▼-0.93%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Gate Bioscience
Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins
Today 8:00 EDT
From
Gate Bioscience
Via
GlobeNewswire
Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic
November 13, 2025
From
Gate Bioscience
Via
GlobeNewswire
INSERTING and REPLACING Gate Bioscience Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Molecular Gate Medicines
July 24, 2025
From
Gate Bioscience
Via
Business Wire
Gate Bioscience Appoints Industry Veteran Jeff Hatfield to Board of Directors
August 29, 2024
From
Gate Bioscience
Via
Business Wire